Crystal Beiting; Vice President, Investor Relations and Financial Planning and Analysis; J M Smucker Co. Mark Smucker; Chairman of the Board, President, Chief Execut ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...